about
MRI in multiple myeloma: a pictorial review of diagnostic and post-treatment findingsBone imaging in prostate cancer: the evolving roles of nuclear medicine and radiologyRadium-223 Therapy for Patients with Metastatic Castrate-Resistant Prostate Cancer: An Update on Literature with Case PresentationEffect of arterial deprivation on growing femoral epiphysis: quantitative magnetic resonance imaging using a piglet model.Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.Assessing response to treatment of bone metastases from breast cancer: what should be the standard of care?The role of radiotherapy in bone metastases: A critical review of current literature.Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.Calcaneal cysts and lipomas: a common pathogenesis?Magnetic resonance-guided focused ultrasound for the treatment of painful bone metastases: role of apparent diffusion coefficient (ADC) and dynamic contrast enhanced (DCE) MRI in the assessment of clinical outcome.Synthetic MRI of the knee: new perspectives in musculoskeletal imaging and possible applications for the assessment of bone marrow disorders.The diagnostic value of SE MRI and DWI of the spine in patients with monoclonal gammopathy of undetermined significance, smouldering myeloma and multiple myeloma.Study of proximal femoral bone perfusion with 3D T1 dynamic contrast-enhanced MRI: a feasibility study.Use of apparent diffusion coefficient as a response biomarker in bone: effect of developing sclerosis on quantified values.Multimodal imaging of bone metastases: From preclinical to clinical applications
P2860
Q26750794-DFF54A88-2677-4797-AED1-8A5DB283D20CQ28071705-72A4F361-A04E-4243-88BA-8F3930DC4202Q28077633-F8C1AB5B-E2E0-4B3D-AE22-3BD3D601B74FQ35620000-F79A2EA7-A487-4436-9604-836076CE2612Q35879087-FD5211B7-2034-4222-8CDF-71ED9CE273C3Q38282521-63C43A37-1EF2-43FB-81D1-DD2B6B0399DEQ38717986-E2AD9789-5173-43BB-AFB3-36BAC17C8631Q39176990-510260EE-7B38-4BB0-9D43-E468489C2629Q39375049-8DD9B275-10A9-480C-B401-8FF04E16E1DAQ39447376-A817755D-B031-4742-AAC3-292743113FACQ48296475-F63C921F-B1F2-41F6-B4C1-63D0F92BB4CDQ49053215-55B61C3E-8334-4F48-857E-13E5784F6864Q50462701-CFA99963-5FC8-4F62-9AAB-1DAD5876B3D7Q53087798-CF759BC8-79DC-4536-BDF6-8A74D48971B0Q56156782-3F2ED95B-818F-483A-BCEC-492927B85C2D
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
MRI for response assessment in metastatic bone disease.
@en
type
label
MRI for response assessment in metastatic bone disease.
@en
prefLabel
MRI for response assessment in metastatic bone disease.
@en
P2093
P2860
P1433
P1476
MRI for response assessment in metastatic bone disease
@en
P2093
B C Vande Berg
F E Lecouvet
V Pasoglou
P2860
P2888
P304
P356
10.1007/S00330-013-2792-3
P407
P577
2013-03-01T00:00:00Z